Rituximab for refractory ocular symptoms in myasthenia gravis with thyroid eye disease: a case report with quantitative MRI assessment

AimsTo report a case with concurrent myasthenia gravis (MG) and thyroid eye disease (TED) showing response to rituximab (RTX) through both clinical evaluation and quantitative MRI assessment.MethodsA 31-year-old female patient with refractory ocular symptoms from concurrent MG and TED received RTX a...

Cijeli opis

Bibliografski detalji

Glavni autori:	Dingxian He, Xiangwen Li, Baitong Wang, Yaqi Wang, Chong Yan, Mengxiao Liu, Tom Hibert, Sushan Luo, Chongbo Zhao, Jianying Xi
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-11-01
Serija:	Frontiers in Immunology
Teme:	myasthenia gravis rituximab thyroid eye disease ocular symptoms magnetic resonance imaging
Online pristup:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1717260/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!